FDA
approval
· 2022-03-03
FDA Approved: DILANTIN-125 — Supplemental Application (Viatris Specialty LLC)
Summary
The FDA approved a supplemental application for DILANTIN-125 (phenytoin) from Viatris Specialty LLC, adding a supplemental dosage strength/formulation to the ap…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for DILANTIN-125 (PHENYTOIN)